https://www.selleckchem.com/pr....oducts/gsk2879552-2h
We have shown that disease progression as assessed by balance and physical functioning is slower in SCA10 patients than SCA3 patients, particularly after 10years of disease. These findings are important as they can help to characterize the disease, assisting in the development of new therapies and rehabilitation programs. We have shown that disease progression as assessed by balance and physical functioning is slower in SCA10 patients than SCA3 patients, particularly after 10 years of disease. These findings are important as the
Like
Comment
Share
